2022
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
O’Toole D, Kunz P, Webb S, Goldstein G, Khawaja S, McDonnell M, Boiziau S, Gueguen D, Houchard A, Ribeiro-Oliveira A, Prebtani A. PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. Advances In Therapy 2022, 40: 671-690. PMID: 36502449, PMCID: PMC9741754, DOI: 10.1007/s12325-022-02360-6.Peer-Reviewed Original ResearchConceptsInjection site painNeuroendocrine tumorsInjection experienceRecent injectionLanreotide autogel/depotMultivariate logistic regression modelOdds of painSomatostatin analogue therapyProportion of patientsInjection site reactionsLogistic regression modelsSSA useAnalogue therapySecondary endpointsDisease subgroupsPainPatientsAcromegalyInjection modalitiesMonthsInjectionTumors
2011
Long-term survivorship in gastric cancer.
Kunz P, Gubens M, Fisher G, Ford J, Lichtensztajn D, Clarke C. Long-term survivorship in gastric cancer. Journal Of Clinical Oncology 2011, 29: 14-14. DOI: 10.1200/jco.2011.29.4_suppl.14.Peer-Reviewed Original ResearchGastric cancerIntestinal histologyGEJ cancerAnatomic sitesAsian/Pacific Islander raceEsophagus/cardiaLonger median OSOutcomes of survivalCalifornia Cancer RegistryYear of diagnosisGastroesophageal junction adenocarcinomaPacific Islander raceCause-specific deathKaplan-Meier curvesLong-term survivorsStrong independent predictorCases of gastricAsian/Pacific IslandersLong-term survivorshipNon-Hispanic whitesHigher SESLogistic regression modelsMedian OSMedian ageIndependent predictorsLong-term survivorship in pancreatic adenocarcinoma.
Gubens M, Kunz P, Fisher G, Ford J, Lichtensztajn D, Clarke C. Long-term survivorship in pancreatic adenocarcinoma. Journal Of Clinical Oncology 2011, 29: 175-175. DOI: 10.1200/jco.2011.29.4_suppl.175.Peer-Reviewed Original ResearchLong-term survivalLong-term survivorsStage diseasePancreatic adenocarcinomaPancreatic cancerAcademic hospitalSocioeconomic statusHigher long-term survivalMultivariate logistic regression modelPrior cancer historyCalifornia Cancer RegistryMonths of diagnosisRegional-stage diseasePopulation-based registryCase-control studyAsian/Pacific IslandersNon-Hispanic blacksUse of tumorLong-term survivorshipNon-Hispanic whitesLogistic regression modelsHigher socioeconomic statusRace/ethnicityMedian survivalMetastatic disease